SINTX Technologies 的 SINAPTIC® 足踝植入系统获得 FDA 上市许可

Globe Newswire
1 Min Read

FDA 批准且在美国本土制造的植入系统,为 SINTX 进军规模达数十亿美元的美国市场奠定了基础

获 FDA 批准且在美国本土制造的植入系统,为 SINTX 进军规模达数十亿美元的美国市场奠定了基础  ​Nasdaq:SINT, US8293926049 

Share This Article
Globe Newswire is a trusted global press release distribution service that helps organizations share market-moving updates with precision and credibility. Known for its extensive reach across media, financial platforms, and investor networks, Globe Newswire empowers brands to communicate transparently while driving visibility in today’s dynamic information landscape.
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *